{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:40:09Z","timestamp":1790642409868,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,8]],"date-time":"2019-12-08T00:00:00Z","timestamp":1575763200000},"content-version":"am","delay-in-days":341,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002224","name":"Melanoma Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002224","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005190","name":"Melanoma Research Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005190","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA125970"],"award-info":[{"award-number":["R01 CA125970"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-09-1-0675"],"award-info":[{"award-number":["W81XWH-09-1-0675"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.ajo.2018.08.045","type":"journal-article","created":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T03:23:40Z","timestamp":1536290620000},"page":"168-179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["Are Risk Factors for Growth of Choroidal Nevi Associated With Malignant Transformation? Assessment With a Validated Genomic Biomarker"],"prefix":"10.1016","volume":"197","author":[{"given":"J. William","family":"Harbour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3488-9680","authenticated-orcid":false,"given":"Manuel","family":"Paez-Escamilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott D.","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Augsburger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zelia M.","family":"Correa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ajo.2018.08.045_bib1","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1167\/iovs.07-1603","article-title":"Size overlap between benign melanocytic choroidal nevi and choroidal malignant melanomas","volume":"49","author":"Augsburger","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"10.1016\/j.ajo.2018.08.045_bib2","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S0161-6420(80)35201-9","article-title":"The differential diagnosis of posterior uveal melanoma","volume":"87","author":"Shields","year":"1980","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1016\/j.ajo.2018.08.045_bib3","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1136\/bjo.73.11.911","article-title":"Clinical parameters predictive of enlargement of melanocytic choroidal lesions","volume":"73","author":"Augsburger","year":"1989","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2018.08.045_bib4","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S0161-6420(94)31274-7","article-title":"Natural history of indeterminate pigmented choroidal tumors","volume":"101","author":"Butler","year":"1994","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2018.08.045_bib5","series-title":"Encyclopedia of Ophthalmology","first-page":"1","article-title":"Indeterminate melanocytic lesions of the choroid","author":"Gragoudas","year":"2015"},{"issue":"3","key":"10.1016\/j.ajo.2018.08.045_bib6","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0002-9394(77)90726-7","article-title":"Problems in the differential diagnosis of choroidal nevi and malignant melanomas. The XXXIII Edward Jackson Memorial Lecture","volume":"83","author":"Gass","year":"1977","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2018.08.045_bib7","first-page":"19","article-title":"Problems in the differential diagnosis of choroidal nevi and malignant melanoma. XXXIII Edward Jackson Memorial lecture","volume":"83","author":"Gass","year":"1977","journal-title":"Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol"},{"issue":"12","key":"10.1016\/j.ajo.2018.08.045_bib8","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1001\/archopht.1997.01100160707007","article-title":"Factors predictive of growth and treatment of small choroidal melanoma: COMS Report No. 5. The Collaborative Ocular Melanoma Study Group","volume":"115","author":"COMS","year":"1997","journal-title":"Arch Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2018.08.045_bib9","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1001\/archophthalmol.2009.151","article-title":"Choroidal nevus transformation into melanoma: analysis of 2514 consecutive cases","volume":"127","author":"Shields","year":"2009","journal-title":"Arch Ophthalmol"},{"issue":"9","key":"10.1016\/j.ajo.2018.08.045_bib10","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1001\/archopht.124.9.1344","article-title":"Treating some small melanocytic choroidal lesions without waiting for growth","volume":"124","author":"Shields","year":"2006","journal-title":"Arch Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2018.08.045_bib11","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1136\/bjo.2006.090738","article-title":"Long term ultrasonic follow up of choroidal naevi and their transformation to melanomas","volume":"90","author":"Kaiserman","year":"2006","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2018.08.045_bib12","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0161-6420(84)34243-9","article-title":"Do growth and onset of symptoms of uveal melanomas indicate subclinical metastasis?","volume":"91","author":"Zimmerman","year":"1984","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.ajo.2018.08.045_bib13","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1001\/archopht.123.10.1457-b","article-title":"Growing melanocytic tumor is not always cancer","volume":"123","author":"Abramson","year":"2005","journal-title":"Arch Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2018.08.045_bib14","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1001\/archopht.122.12.1876","article-title":"Histopathology of documented growth in small melanocytic choroidal tumors","volume":"122","author":"Elner","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2018.08.045_bib15","doi-asserted-by":"crossref","first-page":"7205","DOI":"10.1158\/0008-5472.CAN-04-1750","article-title":"Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death","volume":"64","author":"Onken","year":"2004","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.ajo.2018.08.045_bib16","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1158\/1078-0432.CCR-06-2401","article-title":"Transcriptomic versus chromosomal prognostic markers and clinical outcome in uveal melanoma","volume":"13","author":"Worley","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"8","key":"10.1016\/j.ajo.2018.08.045_bib17","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/sj.eye.6702779","article-title":"Significance of gene expression analysis in uveal melanoma in comparison to standard risk factors for risk assessment of subsequent metastases","volume":"22","author":"Petrausch","year":"2007","journal-title":"Eye"},{"issue":"10","key":"10.1016\/j.ajo.2018.08.045_bib18","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1136\/bjo.2007.116947","article-title":"Reduced expression of autotaxin predicts survival in uveal melanoma","volume":"91","author":"Singh","year":"2007","journal-title":"Br J Ophthalmol"},{"issue":"10","key":"10.1016\/j.ajo.2018.08.045_bib19","doi-asserted-by":"crossref","first-page":"4254","DOI":"10.1167\/iovs.08-2033","article-title":"Gene expression profiling in uveal melanoma: two regions on 3p related to prognosis","volume":"49","author":"van Gils","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"10.1016\/j.ajo.2018.08.045_bib20","doi-asserted-by":"crossref","first-page":"567","DOI":"10.2353\/jmoldx.2006.060077","article-title":"Prognostic testing in uveal melanoma by transcriptomic profiling of fine needle biopsy specimens","volume":"8","author":"Onken","year":"2006","journal-title":"J Mol Diagn"},{"issue":"4","key":"10.1016\/j.ajo.2018.08.045_bib21","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2353\/jmoldx.2010.090220","article-title":"An accurate, clinically feasible multi-gene expression assay for predicting metastasis in uveal melanoma","volume":"12","author":"Onken","year":"2010","journal-title":"J Mol Diagn"},{"issue":"9","key":"10.1016\/j.ajo.2018.08.045_bib22","doi-asserted-by":"crossref","first-page":"4602","DOI":"10.1158\/0008-5472.CAN-05-4196","article-title":"Functional gene expression analysis uncovers phenotypic switch in aggressive uveal melanomas","volume":"66","author":"Onken","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajo.2018.08.045_bib23","first-page":"590659","article-title":"Clinical findings and genetic expression profiling of three pigmented lesions of the optic nerve","volume":"2015","author":"de Alba","year":"2015","journal-title":"Case Rep Ophthalmol Med"},{"issue":"3","key":"10.1016\/j.ajo.2018.08.045_bib24","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/CMR.0b013e3283005270","article-title":"Prognostic biomarkers in uveal melanoma: evidence for a stem cell-like phenotype associated with metastasis","volume":"18","author":"Chang","year":"2008","journal-title":"Melanoma Res"},{"issue":"8","key":"10.1016\/j.ajo.2018.08.045_bib25","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/j.ophtha.2012.02.017","article-title":"Collaborative Ocular Oncology Group report number 1: prospective validation of a multi-gene prognostic assay in uveal melanoma","volume":"119","author":"Onken","year":"2012","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ajo.2018.08.045_bib26","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00417-013-2515-0","article-title":"Sufficiency of FNAB aspirates of posterior uveal melanoma for cytologic versus GEP classification in 159 patients, and relative prognostic significance of these classifications","volume":"252","author":"Correa","year":"2014","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2018.08.045_bib27","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13000-017-0650-3","article-title":"Gene expression profiling in uveal melanoma: technical reliability and correlation of molecular class with pathologic characteristics","volume":"12","author":"Plasseraud","year":"2017","journal-title":"Diagn Pathol"},{"issue":"5","key":"10.1016\/j.ajo.2018.08.045_bib28","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.ajo.2018.08.045_bib29","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archopht.1993.01090060077026","article-title":"Choroidal neovascularization associated with choroidal nevi","volume":"111","author":"Callanan","year":"1993","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2018.08.045_bib30","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0002-9394(03)00868-7","article-title":"Optical coherence tomography in the evaluation of retinal changes associated with suspicious choroidal melanocytic tumors","volume":"137","author":"Espinoza","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2018.08.045_bib31","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/978-1-62703-727-3_22","article-title":"A prognostic test to predict the risk of metastasis in uveal melanoma based on a 15-gene expression profile","volume":"1102","author":"Harbour","year":"2014","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.ajo.2018.08.045_bib32","article-title":"The DecisionDx-UM gene expression profile test provides risk stratification and individualized patient care in uveal melanoma","volume":"5","author":"Harbour","year":"2013","journal-title":"PLoS Curr"},{"issue":"7","key":"10.1016\/j.ajo.2018.08.045_bib33","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1001\/jamaophthalmol.2016.0913","article-title":"Prognostic implications of tumor diameter in association with gene expression profile for uveal melanoma","volume":"134","author":"Walter","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ajo.2018.08.045_bib34","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ajo.2015.11.019","article-title":"Independent prognostic significance of gene expression profile class and largest basal diameter of posterior uveal melanomas","volume":"162","author":"Correa","year":"2016","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2018.08.045_bib35","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00417-017-3856-x","article-title":"Association between traditional clinical high-risk features and gene expression profile classification in uveal melanoma","volume":"256","author":"Nguyen","year":"2018","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2018.08.045_bib36","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/archophthalmol.2010.166","article-title":"Mortality after diagnosis of small melanocytic lesions of the choroid","volume":"128","author":"Lane","year":"2010","journal-title":"Arch Ophthalmol"},{"issue":"9","key":"10.1016\/j.ajo.2018.08.045_bib37","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1001\/archopht.124.9.1342","article-title":"The case for observational management of suspected small choroidal melanoma","volume":"124","author":"Murray","year":"2006","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2018.08.045_bib38","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0008-4182(04)80005-X","article-title":"Clinical factors in the identification of small choroidal melanoma","volume":"39","author":"Shields","year":"2004","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.ajo.2018.08.045_bib39","doi-asserted-by":"crossref","unstructured":"Harbour JW. Prognostic implications of the largest basal tumor diameter vs the TNM staging system in association with the gene expression profile for uveal melanoma-Reply. JAMA Ophthalmol. https:\/\/doi.org\/10.1001\/jamaophthalmol.2016.5109. 2017.01.05.","DOI":"10.1001\/jamaophthalmol.2016.5109"},{"issue":"4","key":"10.1016\/j.ajo.2018.08.045_bib40","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/eye.2017.22","article-title":"Primary photodynamic therapy with verteporfin for small pigmented posterior pole choroidal melanoma","volume":"31","author":"Fabian","year":"2017","journal-title":"Eye (Lond)"},{"issue":"6009","key":"10.1016\/j.ajo.2018.08.045_bib41","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1126\/science.1194472","article-title":"Frequent mutation of BAP1 in metastasizing uveal melanomas","volume":"330","author":"Harbour","year":"2010","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.ajo.2018.08.045_bib42","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41467-017-02428-w","article-title":"Punctuated evolution of canonical genomic aberrations in uveal melanoma","volume":"9","author":"Field","year":"2018","journal-title":"Nat Commun"},{"issue":"10","key":"10.1016\/j.ajo.2018.08.045_bib43","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1016\/j.ophtha.2005.06.011","article-title":"Estimating the risk of malignant transformation of a choroidal nevus","volume":"112","author":"Singh","year":"2005","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ajo.2018.08.045_bib44","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1186\/1471-2407-13-371","article-title":"BAP1 deficiency causes loss of melanocytic cell identity in uveal melanoma","volume":"13","author":"Matatall","year":"2013","journal-title":"BMC Cancer"},{"issue":"7","key":"10.1016\/j.ajo.2018.08.045_bib45","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1001\/jamaophthalmol.2016.0903","article-title":"Driver mutations in uveal melanoma: associations with gene expression profile and patient outcomes","volume":"134","author":"Decatur","year":"2016","journal-title":"JAMA Ophthalmol"},{"issue":"15","key":"10.1016\/j.ajo.2018.08.045_bib46","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/onc.2012.281","article-title":"Challenging the axiom: does the occurrence of oncogenic mutations truly limit cancer development with age?","volume":"32","author":"DeGregori","year":"2013","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.ajo.2018.08.045_bib47","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.4049\/jimmunol.0903479","article-title":"In aged mice, outgrowth of intraocular melanoma depends on proangiogenic M2-type macrophages","volume":"185","author":"Ly","year":"2010","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.ajo.2018.08.045_bib48","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.cmet.2013.03.009","article-title":"Impaired cholesterol efflux in senescent macrophages promotes age-related macular degeneration","volume":"17","author":"Sene","year":"2013","journal-title":"Cell Metab"},{"key":"10.1016\/j.ajo.2018.08.045_bib49","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ctrv.2017.08.009","article-title":"Immune checkpoint blockade for unresectable or metastatic uveal melanoma: a systematic review","volume":"60","author":"Heppt","year":"2017","journal-title":"Cancer Treat Rev"},{"issue":"6","key":"10.1016\/j.ajo.2018.08.045_bib50","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S1470-2045(17)30251-6","article-title":"Treatment of metastatic uveal melanoma with adoptive transfer of tumour-infiltrating lymphocytes: a single-centre, two-stage, single-arm, phase 2 study","volume":"18","author":"Chandran","year":"2017","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.ajo.2018.08.045_bib51","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1158\/1078-0432.CCR-15-2294","article-title":"Identification of an immunogenic subset of metastatic uveal melanoma","volume":"22","author":"Rothermel","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.ajo.2018.08.045_bib52","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jcjo.2016.02.009","article-title":"Swept source optical coherence tomography of choroidal nevi","volume":"51","author":"Michalewska","year":"2016","journal-title":"Can J Ophthalmol"},{"issue":"10","key":"10.1016\/j.ajo.2018.08.045_bib53","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1136\/bjo.2007.116665","article-title":"Fundus autofluorescence of choroidal nevus and melanoma","volume":"91","author":"Lavinsky","year":"2007","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2018.08.045_bib54","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1001\/archopht.1966.03850010786004","article-title":"Histogenesis of malignant melanomas of the uvea. I. Histopathologic characteristics of nevi of the choroid and ciliary body","volume":"76","author":"Naumann","year":"1966","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2018.08.045_bib55","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1158\/1078-0432.CCR-15-2071","article-title":"PRAME as an independent biomarker for metastasis in uveal melanoma","volume":"22","author":"Field","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"37","key":"10.1016\/j.ajo.2018.08.045_bib56","doi-asserted-by":"crossref","first-page":"59209","DOI":"10.18632\/oncotarget.10962","article-title":"Epigenetic reprogramming and aberrant expression of PRAME are associated with increased metastatic risk in Class 1 and Class 2 uveal melanomas","volume":"7","author":"Field","year":"2016","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.ajo.2018.08.045_bib57","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1001\/jamaophthalmol.2017.0729","article-title":"PRAME as a potential target for immunotherapy in metastatic uveal melanoma","volume":"135","author":"Gezgin","year":"2017","journal-title":"JAMA Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2018.08.045_bib58","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.ophtha.2013.12.014","article-title":"A molecular revolution in uveal melanoma: implications for patient care and targeted therapy","volume":"121","author":"Harbour","year":"2014","journal-title":"Ophthalmology"},{"issue":"23","key":"10.1016\/j.ajo.2018.08.045_bib59","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1056\/NEJMoa1000584","article-title":"Mutations in GNA11 in uveal melanoma","volume":"363","author":"Van Raamsdonk","year":"2010","journal-title":"N Engl J Med"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939418305063?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939418305063?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:41:09Z","timestamp":1762080069000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939418305063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":59,"alternative-id":["S0002939418305063"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2018.08.045","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Are Risk Factors for Growth of Choroidal Nevi Associated With Malignant Transformation? Assessment With a Validated Genomic Biomarker","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2018.08.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}